|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 189 HKD | +6.48% |
|
+12.63% | +83.67% |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 1,540.49 million compared to CNY 803.93 million a year ago. Net loss was CNY 574.13 million compared to CNY 616.1 million a year ago.
Basic loss per share from continuing operations was CNY 2.84 compared to CNY 5.74 a year ago. Diluted loss per share from continuing operations was CNY 2.84 compared to CNY 5.74 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +83.67% | 5.3B | |
| +3.91% | 109B | |
| +10.87% | 105B | |
| +1.28% | 22.25B | |
| -13.14% | 22.09B | |
| -7.05% | 18.68B | |
| -38.36% | 17.58B | |
| -10.66% | 16.85B | |
| +3.75% | 13.76B | |
| +36.70% | 12.46B |
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. 